DESMOID FIBROMATOSIS

Clinical trials for DESMOID FIBROMATOSIS explained in plain language.

Never miss a new study

Get alerted when new DESMOID FIBROMATOSIS trials appear

Sign up with your email to follow new studies for DESMOID FIBROMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 3 Completed 1

Cancer drug shows promise in slowing rare tumor growth

Disease control Completed

This Phase 3 trial tested the drug sorafenib in 87 people with desmoid tumors, a rare type of growth that can be painful and invasive. The study compared sorafenib to a placebo to see if it could slow tumor progression. Sorafenib works by blocking proteins that help tumors grow. …

Matched conditions: DESMOID FIBROMATOSIS

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

DESMOID FIBROMATOSIS

Get alerted when new DESMOID FIBROMATOSIS trials appear

Cancer drug shows promise in slowing rare tumor growth